Sung Lee - Net Worth and Insider Trading
Sung Lee Net Worth
The estimated net worth of Sung Lee is at least $1 Million dollars as of 2024-06-01. Sung Lee is the EVP & CFO of Vir Biotechnology Inc and owns about 100,492 shares of Vir Biotechnology Inc (VIR) stock worth over $1 Million. Details can be seen in Sung Lee's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sung Lee has not made any transactions after 2024-03-27 and currently still holds the listed stock(s).
Transaction Summary of Sung Lee
Sung Lee Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sung Lee owns 2 companies in total, including Sangamo Therapeutics Inc (SGMO) , and Vir Biotechnology Inc (VIR) .
Click here to see the complete history of Sung Lee’s form 4 insider trades.
Insider Ownership Summary of Sung Lee
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGMO | Sangamo Therapeutics Inc | 2019-10-31 | EVP & Chief Financial Officer |
| VIR | Vir Biotechnology Inc | 2024-03-27 | Chief Financial Officer |
Sung Lee Latest Holdings Summary
Sung Lee currently owns a total of 1 stock. Sung Lee owns 100,492 shares of Vir Biotechnology Inc (VIR) as of March 27, 2024, with a value of $1 Million.
Latest Holdings of Sung Lee
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VIR | Vir Biotechnology Inc | 2024-03-27 | 100,492 | 10.25 | 1,030,043 |
Holding Weightings of Sung Lee
Sung Lee Form 4 Trading Tracker
According to the SEC Form 4 filings, Sung Lee has made a total of 1 transactions in Vir Biotechnology Inc (VIR) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Vir Biotechnology Inc is the sale of 6,008 shares on March 27, 2024, which brought Sung Lee around $59,419.
Insider Trading History of Sung Lee
- 1
Sung Lee Trading Performance
Sung Lee Ownership Network
Sung Lee Owned Company Details
What does Sangamo Therapeutics Inc do?
Who are the key executives at Sangamo Therapeutics Inc?
Sung Lee is the EVP & Chief Financial Officer of Sangamo Therapeutics Inc. Other key executives at Sangamo Therapeutics Inc include 10 percent owner Biogen Inc. , SVP-Chief Development Officer Nathalie Dubois-stringfellow , and 10 percent owner Biogen Ma Inc. .
Sangamo Therapeutics Inc (SGMO) Insider Trades Summary
Over the past 18 months, Sung Lee made no insider transaction in Sangamo Therapeutics Inc (SGMO). Other recent insider transactions involving Sangamo Therapeutics Inc (SGMO) include a net sale of 6,000,000 shares made by Biogen Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Sangamo Therapeutics Inc (SGMO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 6,000,000 shares of Sangamo Therapeutics Inc (SGMO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 6,000,000 shares.
Sangamo Therapeutics Inc (SGMO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sangamo Therapeutics Inc Insider Transactions
Sung Lee Mailing Address
Above is the net worth, insider trading, and ownership report for Sung Lee. You might contact Sung Lee via mailing address: 7000 Marina Blvd, Brisbane Ca 94005.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
